Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Subst Abuse Treat. 2016 Mar 14;66:23–29. doi: 10.1016/j.jsat.2016.03.001

Table 2. Characteristics of Study Sample, 2003 and 2010.

2003 2010
N % SE N % SE
Total (weighted N) (7529) (8427)
Product type
 HMO 2206 29.3 0.9 2420 28.7 0.7
 PPO 2703 35.9 1.6 3004 35.7 0.6
 POS 2613 34.7 1.3 2613 31.0 0.4
 CDP (consumer directed product) 0 0.0 0.0 390 4.6 0.6
Behavioral health contract
 Specialty External (MBHO) 5474 72.7 3.2 1251 14.8 2.3
 Hybrid Internal 911 12.1 2.2 5899 70.0 3.3
 Internal 1144 15.2 2.3 1278 15.2 2.2
Pharmacy benefits manager (PBM) contract
 Yes 4028 53.5 2.2 6150 73.0 1.9
 No 3501 46.5 2.2 2277 27.0 1.9
Profit status
 For-profit 6445 85.6 2.3 7390 87.7 2.0
 Non-profit 1084 14.4 2.3 1037 12.3 2.0